News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Keeping up the PACE at the Scottish Medicines Consortium (SM... There are many ways that patient centricity could be delivered when doing a health technology assessment (HTA).
Views & Analysis The shadow of Brexit on speed of access No-one can miss the ongoing saga that is the UK’s exit from the European Union (EU).
Views & Analysis Access to new medicines in Scotland: a perennial issue Access to new medicines in Scotland – just as it would seem is the case everywhere – is always on the agenda.
News Summit climbs on rumour of $15bn AstraZeneca interest Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
